GlaucoT
GlaucoT
  • Home
  • About
  • Glaucoma
  • Team
  • Clinical Study
  • Contact
  • More
    • Home
    • About
    • Glaucoma
    • Team
    • Clinical Study
    • Contact
  • Home
  • About
  • Glaucoma
  • Team
  • Clinical Study
  • Contact
data:image/gif;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=

Innovation for Sight

Innovation for SightInnovation for SightInnovation for Sight

The Next Generation 

Glaucoma Treatment Platform

Innovation for Sight

Innovation for SightInnovation for SightInnovation for Sight

The Next Generation 

Glaucoma Treatment Platform

The World's First Neuroprotective Glaucoma Treatment Device

GlaucoT is a smart wearable device designed for gamma rhythm entrainment in order to reduce neuroinflammation.

 GlaucoT - A new personalized neuroprotective glaucoma treatment device!

Gamma Rhythm Entrainment

'How neuroprotection works by flickering light on Alzheimer's disease?' by MIT. 

Alzheimer's disease and Glaucoma has same pathophysiology!

Benefits

Wearable tech device for "at home" treatment

Patient will use GlaucoT at home, with pleasure by their prefered time and will get rid of glaucoma. You could get pleasure of drinking coffee when you are wearing GlaucoT and treat your glaucoma!

Noninvasive Treatment

This is a simple medical consumer electronic device. You don't need to have any surgery or operation to use it so its a non-invasive treatment.

RESERVE a Meeting

RESERVE a Meeting

RESERVE a Meeting

Please make your booking for get more information either at physically at CES Eureka Park or Online



WE ARE IN IT!

EUREKA PARK 

Booth # 63519

JAN 5-8, 2023

LAS VEGAS, NV & DIGITAL


RESERVE a Meeting

CES 2023

RESERVE a Meeting

RESERVE a Meeting


WE ARE IN IT!

JAN 5-8, 2023

LAS VEGAS, NV & DIGITAL


 We are attending to Eureka Park™ at CES 2023. Eureka Park™ at CES® is where new ideas are funded. It’s the buzzworthy startup arena that provides a unique opportunity to launch a new product, service or idea. We are looking forward to meeting with the potential customers and investers at Eureka Park.

EIT Health

RESERVE a Meeting

Start Up Stadium BIO USA

We are really excited to be selected for the EIT Health 2022 Catapult Program. The programme recognises and awards the very best business concepts, fast-tracking start-ups to become part of the EIT Health Community of world-leading companies.

Start Up Stadium BIO USA

Selected to BIO International Con.

Start Up Stadium BIO USA

 It is our pleasure to announce that our start-up “GlaucoT” has been selected among 16 companies to present at the Start-Up Stadium event from hundreds of startups and entrepreneurs from around the world. We will have the opportunity to introduce Glaucot and our innovation “Wearable Glaucoma Treatment Device” to key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital. 

Selected to BIO International Con.

Selected to BIO International Con.

Selected to BIO International Con.

GlaucoT has been selected among 5 startup to participate in the  Bio Convention in the USA


BIOStartup Demo Day supported by Association of Research-Based Pharmaceutical Companies in Turkey AiFD


more info about event from here


#AiFD #Biostartup #Glaucoma #GlacuoT #TTGV HIT


Glaucot is Number 1

Selected to BIO International Con.

Selected to BIO International Con.

 GlaucoT won first place out of 471 projects participating in TET R&D Project Brokerage Event organized by TET - Electrical and Electronics Exporters Association  


https://www.tetprojepazari.org/tr/Default.aspx


Göz Tansiyonu (glokom) Tedavisi için geliştirdiğimiz GlaucoT projemiz TET Tarafından düzenlenen 9. Proje Pazarın etkinliğinde 471 proje arasından birinci seçildi. Tüm ekibimize ve bu projede bize destek olan TTGV HIT programına teşekkür ediyoruz.  #glokom #glaucoma #ttgv #immib
 

TTGV HIT Acceleration Program

TTGV HIT Acceleration Program

TTGV HIT Acceleration Program

 GlaucoT, World First, noninvasive neuroprotective Glacuoma treatment device on the way, pleasure to get support from TTGV HIT
GlaucoT, dünyanın ilk noninvaziv nöroprotektif Glokom (Göz Tansiyonu) tedavi cihazı yolda, TTGV HIT'den destek almak gurur verici
#TeknolojiÜretenTürkiye #TTGV #glaucoma #glokom #göztansiyonu #innovation #HitProgramı #GlaucoT 

Acıbadem Incubator

TTGV HIT Acceleration Program

TTGV HIT Acceleration Program

Our Co-founder Dr. Abdülkadir Oduncu has attended immense training at Acıbadem Incubation center for GlaucoT project commercialization

Contact Us

Let us know what we can do for you

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Better yet, see us in person!

We would love to meet with our doctors, investors and patients! So feel free to visit us during daily business hours.

GlaucoT

Reşit Paşa Mah. Katar Cad. ARI 4 Binası No: 2 / 50 / 6 Sarıyer – İstanbul, 34467 SARIYER/İstanbul

+90 212 982 22 66

Hours

Open today

09:00 am – 05:00 pm

Copyright © 2021 GlaucoT - All Rights Reserved.